Ikena Oncology Inc.

NASDAQ: IKNA · Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM

Ikena Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 9.16M 15.62M 30.98M
Cost of Revenue
n/a 1.02M 2.03M 47.11M
Gross Profit
n/a 8.14M 13.58M -16.12M
Operating Income
-58.97M -75.42M -70.9M -34.14M
Interest Income
n/a 7.11M 2.15M 23K
Pretax Income
-49.08M -68.33M -68.77M -34.12M
Net Income
-49.23M -68.17M -66.63M -34.12M
Selling & General & Admin
23.68M 24.93M 22.2M 18.02M
Research & Development
30.39M 59.65M 64.32M 47.11M
Other Expenses
4.42M n/a -10K 23K
Operating Expenses
58.97M 84.58M 86.52M 65.12M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 84.58M 86.52M 65.12M
Income Tax Expense
152K -162K -2.14M 307.44K
Shares Outstanding (Basic)
48.26M 41.74M 36.19M 35.98M
Shares Outstanding (Diluted)
48.26M 41.74M 36.19M 35.98M
EPS (Basic)
-1.02 -1.63 -1.84 -0.95
EPS (Diluted)
-1.02 -1.63 -1.84 -0.95
EBITDA
-48.59M -74.4M -70.15M -33.59M
EBIT
-49.08M -75.42M -70.9M -34.14M
Depreciation & Amortization
490K 1.02M 2.03M 1.72M